Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Bortezomib for Injection

Approval Number

国药准字H20258062

Company江苏诚康药业有限公司

Registration Date

April 9, 2025

Previous Approval Numbers

国药准字H20234692

Drug Information

Generic Name

注射用硼替佐米

Dosage Form

注射剂

Strength

1.0mg

Drug Type

化学药品

Registration Date

April 9, 2025

Company Information

Applicant Company

Company Name江苏诚康药业有限公司

Company Address

江苏大丰盐土大地海洋生物产业科技园

Manufacturing Company

Company Name江苏诚康药业有限公司

Company Address

江苏大丰盐土大地海洋生物产业科技园

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy